Listing 1 - 4 of 4 |
Sort by
|
Choose an application
Chronic obstructive pulmonary disease or COPD is a disease that poses a double threat to the population. On one hand, because of its ever-increasing prevalence, it will be the third highest on the list of life-threatening diseases by 2020. On the other hand, the irreversible nature of this disease, and the fact that therapeutic treatments can only slow respiratory decline, accentuate its physical and psychological harm on the patient and its economic impact on society. Respiratory rehabilitation, which is based on a set of non-pharmacological methods, is aimed at improving the quality of life of the patient on a daily basis and decreasing the frequency of exacerbations and hospitalizations. Pharmacological treatment of COPD revolves mainly around β2-Mimetic bronchodilators and anticholinergics. Those derivatives having a short term action are used in the treatment of specific attacks; those having a long term action are used to the public. Responses, although few, highlighted and abusive use of fast-acting bronchodilators, poor compliance to the various treatments, improper use of inhalers and continued tobacco use. These findings should convince the pharmacist to continue his efforts to improve these aspects among his patients whilst providing frequent advices with clear explanations La broncho-pneumopathie chronique obstructive ou BPCO est une maladie qui se présente comme une double menace pour la population. En effet, d’une part à cause de sa prévalence sans cesse croissante elle occupera en 2020 la troisième place sur la liste des affections mortelles. D’autre part, le caractère irréversible de cette maladie et les traitements thérapeutiques limités à un ralentissement du déclin respiratoire accentuent ses méfaits physiques et psychologiques sur le malade et son impact économique sur la société. La réhabilitation respiratoire qui se présente comme un ensemble de méthodes non pharmacologiques a pour objectif une amélioration de la qualité de vie du malade au quotidien et une diminution de la fréquence des exacerbations et des hospitalisations. Le traitement pharmacologique de la BPCO s’articule principalement autour des bronchodilatateurs β2-mimétiques et des anticholinergiques. Les dérivés à courte durée d’action déterminent le traitement de crises, ceux à longue durée d’action le traitement de fond. Une enquête personnelle a été réalisée dans des officines ouvertes au public. Les réponses obtenues quoique peu nombreuses mettent en évidence une consommation abusive des bronchodilatateurs à action rapide, une mauvaise compliance des différents traitements, une mauvaise utilisation des inhalateurs et un sevrage tabagique insuffisant. Ces conclusions doivent convaincre le pharmacien de poursuivre ses efforts pour améliorer ces différents aspects parmi sa patientèle tout en prodiguant des conseils fréquents avec des explications claires
Choose an application
Pulmonary Disease, Chronic Obstructive --- Streptococcus --- Methotrimeprazine --- Fluoroquinolones
Choose an application
Palliative Care --- Pulmonary Disease, Chronic Obstructive --- Hospitals, University
Choose an application
Smoking and Lung Inflammation is the first book directly related to chronic lung inflammation of its kind in several respects. First, the it focuses on both basic and clinical research on COPD, and the inflammatory mechanisms that function in these diseases. Second, it is unique with respect to scope of the discussion of the unusual characteristics of the immune response which occurs in these patients. Third, it includes knowledge being gained from translational research conducted through clinical trials at several Medical Schools in the United States. Not only is this research providing information about novel drugs and therapies, but it is also advancing our understanding of the genetics of these diseases. This work will illuminate the molecular basis for these diseases, and hopefully will permit us to individualize the therapies for these diseases.
Immunology. --- Lungs -- Diseases, Obstructive. --- Pneumonia. --- Tobacco -- Physiological effect. --- Lungs --- Habits --- Lung Diseases, Obstructive --- Lung Diseases --- Behavior --- Respiratory Tract Diseases --- Behavior and Behavior Mechanisms --- Psychiatry and Psychology --- Diseases --- Pulmonary Disease, Chronic Obstructive --- Smoking --- Biology --- Health & Biological Sciences --- Microbiology & Immunology --- Diseases, Obstructive --- Medicine. --- Pneumology. --- Health aspects. --- Clinical sciences --- Medical profession --- Immunobiology --- Respiratory organs --- Pathology. --- Biomedicine. --- Pneumology/Respiratory System. --- Diseases. --- Human biology --- Life sciences --- Medical sciences --- Pathology --- Physicians --- Serology --- Disease (Pathology) --- Medicine --- Medicine, Preventive --- Respiratory organs—Diseases.
Listing 1 - 4 of 4 |
Sort by
|